Perseus Proteomics (TSE:4882) Days Sales Outstanding : 62.83 (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Perseus Proteomics Days Sales Outstanding?

Perseus Proteomics's average Accounts Receivable for the three months ended in Dec. 2023 was 円14.29 Mil. Perseus Proteomics's Revenue for the three months ended in Dec. 2023 was 円20.75 Mil. Hence, Perseus Proteomics's Days Sales Outstanding for the three months ended in Dec. 2023 was 62.83.

The historical rank and industry rank for Perseus Proteomics's Days Sales Outstanding or its related term are showing as below:

TSE:4882' s Days Sales Outstanding Range Over the Past 10 Years
Min: 38.61 Med: 48.89 Max: 440.32
Current: 39.76

During the past 6 years, Perseus Proteomics's highest Days Sales Outstanding was 440.32. The lowest was 38.61. And the median was 48.89.

TSE:4882's Days Sales Outstanding is ranked better than
80.06% of 998 companies
in the Drug Manufacturers industry
Industry Median: 71.845 vs TSE:4882: 39.76

Perseus Proteomics's Days Sales Outstanding increased from Dec. 2022 (38.69) to Dec. 2023 (62.83).

Perseus Proteomics Days Sales Outstanding Historical Data

The historical data trend for Perseus Proteomics's Days Sales Outstanding can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Perseus Proteomics Days Sales Outstanding Chart

Perseus Proteomics Annual Data

Trend

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Days Sales Outstanding

Get a 7-Day Free Trial

156.68

440.32

49.92

47.86

38.61

Perseus Proteomics Quarterly Data
	Mar18	Mar19	Dec19	Mar20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Days Sales Outstanding	Get a 7-Day Free Trial												38.69	24.80	37.40	44.37	62.83

Competitive Comparison of Perseus Proteomics's Days Sales Outstanding

For the Drug Manufacturers - General subindustry, Perseus Proteomics's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Perseus Proteomics's Days Sales Outstanding Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Perseus Proteomics's Days Sales Outstanding distribution charts can be found below:

* The bar in red indicates where Perseus Proteomics's Days Sales Outstanding falls into.

Perseus Proteomics Days Sales Outstanding Calculation

Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Accounts Receivable can be measured by Days Sales Outstanding.

Perseus Proteomics's Days Sales Outstanding for the fiscal year that ended in Mar. 2023 is calculated as

	Days Sales Outstanding (A: Mar. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Mar. 2022 )	+	Accounts Receivable (A: Mar. 2023 ))	/	count )	/	Revenue (A: Mar. 2023 )	*	Days in Period
=	( (10.115	+	9.813)	/	2 )	/	94.201	*	365
=	9.964					/	94.201	*	365
=	38.61

Perseus Proteomics's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding (Q: Dec. 2023 )
=	Average Accounts Receivable					/	Revenue	*	Days in Period
=	( (Accounts Receivable (A: Sep. 2023 )	+	Accounts Receivable (A: Dec. 2023 ))	/	count )	/	Revenue (A: Dec. 2023 )	*	Days in Period
=	( (14.944	+	13.627)	/	2 )	/	20.748	*	365 / 4
=	14.2855					/	20.748	*	365 / 4
=	62.83

Perseus Proteomics (TSE:4882) Days Sales Outstanding Explanation

For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.

Perseus Proteomics Days Sales Outstanding Related Terms

Thank you for viewing the detailed overview of Perseus Proteomics's Days Sales Outstanding provided by GuruFocus.com. Please click on the following links to see related term pages.

Perseus Proteomics (TSE:4882) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Perseus Proteomics Inc (TSE:4882) » Definitions » Days Sales Outstanding

Comparable Companies

Traded in Other Exchanges

N/A

Address

4-7-6, Komaba, Tokyo Park Building, Meguro-ku, Tokyo, JPN, 153-0041

Website

https://www.ppmx.com

Perseus Proteomics Inc is engaged in the research and development, manufacture, and sales of pharmaceuticals. It provides antibody based therapeutics and diagnostics drugs to cure against cancer and other diseases.

Perseus Proteomics (TSE:4882) Headlines

No Headlines